Simplex Trading’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,704
Closed -$1.81M 2370
2025
Q1
$1.81M Buy
6,704
+1,875
+39% +$506K ﹤0.01% 236
2024
Q4
$1.14M Buy
+4,829
New +$1.14M ﹤0.01% 404
2024
Q3
Sell
-8,803
Closed -$2.14M 2214
2024
Q2
$2.14M Buy
+8,803
New +$2.14M ﹤0.01% 267
2024
Q1
Sell
-2,916
Closed -$558K 2298
2023
Q4
$558K Sell
2,916
-3,929
-57% -$752K ﹤0.01% 610
2023
Q3
$1.21M Buy
+6,845
New +$1.21M ﹤0.01% 313
2023
Q2
Sell
-13,723
Closed -$2.75M 2307
2023
Q1
$2.75M Buy
13,723
+4,846
+55% +$970K ﹤0.01% 157
2022
Q4
$2.11M Buy
8,877
+8,868
+98,533% +$2.11M ﹤0.01% 175
2022
Q3
$1K Sell
9
-1,068
-99% -$119K ﹤0.01% 2453
2022
Q2
$157K Buy
+1,077
New +$157K ﹤0.01% 955
2022
Q1
Hold
0
2804
2021
Q4
Sell
-15,991
Closed -$2.71M 2936
2021
Q3
$2.71M Buy
15,991
+707
+5% +$120K ﹤0.01% 223
2021
Q2
$2.59M Buy
15,284
+898
+6% +$152K ﹤0.01% 230
2021
Q1
$2.03M Buy
14,386
+6,311
+78% +$891K ﹤0.01% 194
2020
Q4
$1.05M Buy
8,075
+7,806
+2,902% +$1.01M ﹤0.01% 404
2020
Q3
$39K Buy
+269
New +$39K ﹤0.01% 1404
2020
Q2
Sell
-14,470
Closed -$1.58M 1968
2020
Q1
$1.58M Buy
+14,470
New +$1.58M ﹤0.01% 202
2019
Q4
Hold
0
1895
2019
Q3
Hold
0
1821
2019
Q2
Sell
-2,772
Closed -$259K 1767
2019
Q1
$259K Buy
+2,772
New +$259K ﹤0.01% 590
2018
Q4
Hold
0
1862
2018
Q3
Hold
0
2000
2018
Q2
Hold
0
2016
2018
Q1
Sell
-5,971
Closed -$758K 1933
2017
Q4
$758K Sell
5,971
-6,423
-52% -$815K 0.03% 310
2017
Q3
$1.46M Buy
+12,394
New +$1.46M 0.06% 167
2017
Q2
Sell
-32,718
Closed -$1.68M 1826
2017
Q1
$1.68M Buy
32,718
+24,987
+323% +$1.28M 0.07% 176
2016
Q4
$289K Sell
7,731
-1,025
-12% -$38.3K 0.02% 446
2016
Q3
$593K Sell
8,756
-5,994
-41% -$406K 0.04% 258
2016
Q2
$818K Buy
14,750
+7,648
+108% +$424K 0.05% 199
2016
Q1
$445K Buy
+7,102
New +$445K 0.04% 261
2015
Q4
Sell
-4,335
Closed -$348K 1714
2015
Q3
$348K Sell
4,335
-3,548
-45% -$285K 0.03% 306
2015
Q2
$944K Buy
+7,883
New +$944K 0.08% 148
2015
Q1
Sell
-853
Closed -$83K 1676
2014
Q4
$83K Buy
+853
New +$83K 0.01% 529